Claritas Pharmaceuticals private placement
2022-03-21 16:19 ET - Private Placement
The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement announced on Jan. 17, 2022, and updated on Jan. 26, 2022.
Number of shares: 1,081,081 shares
Purchase price: 13.875 cents per share
Warrants: 1,081,081 share purchase warrants to purchase 1,081,081 shares
Warrant exercise price: Twenty-one cents for a three-year period. The warrants are subject to an acceleration clause such that if the 20-day volume weighted average closing price of company's common shares trading on the TSX Venture Exchange is equal or exceeds 42 cents. In the event of acceleration, the company will have the right, upon providing notice to the holder, to accelerate the warrant expiry date to the date which is not earlier than 30 days following the date of receipt of the notice from the company announcing the reduced warrant terms.
Number of placees: one placee
Insiders/pro groups: none
Finder's fee: none